Company Name: |
3B Pharmachem (Wuhan) International Co.,Ltd.
|
Tel: |
821-50328103-801 18930552037 |
Email: |
3bsc@sina.com |
Products Intro: |
Product Name:MRS 2179 tetrasodiuM salt;2'-Deoxy-N6-Methyladenosine3',5'-bisphosphatetetrasodiuMsalt CAS:101204-49-3 Purity:99% HPLC Package:1Mg ; 5Mg;10Mg ;100Mg;250Mg ;500Mg ;1g;2.5g ;5g ;10g
|
Company Name: |
Sigma-Aldrich
|
Tel: |
021-61415566 800-8193336 |
Email: |
orderCN@merckgroup.com |
Products Intro: |
Product Name:MRS 2179 CAS:101204-49-3 Purity:>=98% (HPLC) Package:5mg, 25mg Remarks:M3808
|
|
| 2'-DEOXY-N6-METHYLADENOSINE 3',5'-BISPHOSPHATE TETRAAMMONIUM SALT Basic information |
Product Name: | 2'-DEOXY-N6-METHYLADENOSINE 3',5'-BISPHOSPHATE TETRAAMMONIUM SALT | Synonyms: | MRS 2179 TETRASODIUM SALT;2'-DEOXY-N6-METHYLADENOSINE 3',5'-BISPHOSPHATE TETRASODIUM SALT;2'-DEOXY-N6-METHYLADENOSINE 3',5'-BISPHOSPHATE TETRAAMMONIUM SALT;MRS2179tetraammoniumsalt;MRS2179 hydrate ammonium salt;MRS 2179 ammonium salt hydrate;MRS2179 ammonium salt;[2-[(hydroxy-oxidophosphoryl)oxymethyl]-5-(6-methylaminopurin-9-yl)oxolan-3-yl] hydrogen phosphate | CAS: | 101204-49-3 | MF: | C11H17N5O9P2 | MW: | 425.23 | EINECS: | | Product Categories: | | Mol File: | 101204-49-3.mol | |
| 2'-DEOXY-N6-METHYLADENOSINE 3',5'-BISPHOSPHATE TETRAAMMONIUM SALT Chemical Properties |
Boiling point | 821.6±75.0 °C(Predicted) | density | 2.15±0.1 g/cm3(Predicted) | storage temp. | −20°C | solubility | DMSO: 1.1 mg/mL | pka | 1.83±0.10(Predicted) |
| 2'-DEOXY-N6-METHYLADENOSINE 3',5'-BISPHOSPHATE TETRAAMMONIUM SALT Usage And Synthesis |
Uses | MRS 2179 ammonium salt hydrate has been used as a P2Y1 receptor antagonist in porcine coronary small arteries, endothelial cells, and hippocampal astrocytes. | Biological Activity | A competitive antagonist at P2Y 1 receptors (K B = 100 nM). Selective over P2X 1 (IC 50 = 1.15 μ M), P2X 3 (IC 50 = 12.9 μ M), P2X 2 , P2X 4 , P2Y 2 , P2Y 4 and P2Y 6 receptors. | Biochem/physiol Actions | MRS 2179 resists localized venous thrombosis and is useful in treating thrombotic syndromes due to its platelet aggregation inhibition functionality. |
| 2'-DEOXY-N6-METHYLADENOSINE 3',5'-BISPHOSPHATE TETRAAMMONIUM SALT Preparation Products And Raw materials |
|